Drug interaction study in healthy men
Treatments studied
This study tests how another drug (carbamazepine) affects the amount of an investigational drug (verducatib) in the blood of healthy men. It helps determine if the drugs can be given together safely and how they interact.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy male.
- You must be between 18 and 50 years old.
- Your body mass index (BMI) must be between 18.5 and 29.9.
- You must not have any clinically relevant abnormal findings from medical exams or lab tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This study tests how different doses of the drug verducatib affect the heart in healthy adults. Participation helps ensure the drug is safe before it's studied in patients.
This study in healthy volunteers looks at how much of the drug BI 3034701 enters the bloodstream when given in two different ways. It helps find the best way to deliver the drug for future studies.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This trial tests how two experimental drugs, UIC202601 and UIC202602, interact with each other in the body. Healthy volunteers take both drugs to check for side effects and how the body processes them.
This study checks how a new investigational drug (catequentinib) interacts with two other common medications in healthy volunteers. Participation helps understand safe dosing and potential side effects before larger studies.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.